Search Results - "Stephen, Douglas"

Team IHMC's Lessons Learned from the DARPA Robotics Challenge Trials by Johnson, Matthew, Shrewsbury, Brandon, Bertrand, Sylvain, Wu, Tingfan, Duran, Daniel, Floyd, Marshall, Abeles, Peter, Stephen, Douglas, Mertins, Nathan, Lesman, Alex, Carff, John, Rifenburgh, William, Kaveti, Pushyami, Straatman, Wessel, Smith, Jesper, Griffioen, Maarten, Layton, Brooke, de Boer, Tomas, Koolen, Twan, Neuhaus, Peter, Pratt, Jerry

“…This article is a summary of the experiences of the Florida Institute for Human & Machine Cognition (IHMC) team during the DARPA Robotics Challenge (DRC)…”
Get full text

The salience of social context, opioid antagonist use, and prior opioid exposure as determinants of fatal and non-fatal opioid overdoses by Zimmerman, Gregory M., Douglas, Stephen D., Turchan, Brandon S., Braga, Anthony A.

“…This study examines the salience of social context for opioid overdoses in Boston from 2014 to 2019. Longitudinal negative binomial models with random effects…”
Get full text

Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation by Behm, David J, Ogbonna, Andrea, Wu, Charlene, Burns-Kurtis, Cynthia L, Douglas, Stephen A

“…Epoxy- and dihydroxy-eicosatrienoic acids (EETs and DHETs) are vasoactive cytochrome P450 metabolites of arachidonic acid. Interestingly, however, the…”
Get more information

Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: A retrospective observational cohort analysis of 1400 patients with ultrasound screening by Harrison-Brown, Meredith, Scholes, Corey, Douglas, Stephen L, Farah, Sami B, Kerr, Dennis, Kohan, Lawrence

“…Purpose: This study reports the results of a multimodal thromboprophylaxis protocol for lower limb arthroplasty involving risk stratification, intraoperative…”
Get full text

Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice by Steri, Veronica, Ellison, Tim S, Gontarczyk, Aleksander Maksym, Weilbaecher, Katherine, Schneider, Jochen G, Edwards, Dylan, Fruttiger, Marcus, Hodivala-Dilke, Kairbaan M, Robinson, Stephen Douglas

“…RATIONALE:The dramatic upregulation of αvβ3-integrin that occurs in the vasculature during tumor growth has long suggested that the endothelial expression of…”
Get full text

Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase by Thalji, Reema K., McAtee, Jeff J., Belyanskaya, Svetlana, Brandt, Martin, Brown, Gregory D., Costell, Melissa H., Ding, Yun, Dodson, Jason W., Eisennagel, Steve H., Fries, Rusty E., Gross, Jeffrey W., Harpel, Mark R., Holt, Dennis A., Israel, David I., Jolivette, Larry J., Krosky, Daniel, Li, Hu, Lu, Quinn, Mandichak, Tracy, Roethke, Theresa, Schnackenberg, Christine G., Schwartz, Benjamin, Shewchuk, Lisa M., Xie, Wensheng, Behm, David J., Douglas, Stephen A., Shaw, Ami L., Marino, Joseph P.

“…1-(1,3,5-Triazin-yl)piperidine-4-carboxamide inhibitors of soluble epoxide hydrolase were identified from high through-put screening using encoded library…”
Get full text

Congestive heart failure and expression of myocardial urotensin II by Douglas, Stephen A, Tayara, Lara, Ohlstein, Eliot H, Halawa, Nadine, Giaid, Adel

“…Human urotensin II has several cardiovascular actions, including potent vasoactive, and cardiac inotropic and hypertropic properties. Our aim was to ascertain…”
Get full text

Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells by Aiyar, Nambi, Disa, Jyoti, Ao, Zhaohui, Ju, Haisong, Nerurkar, Sandhya, Willette, Robert N, Macphee, Colin H, Johns, Douglas G, Douglas, Stephen A

“…Lysophosphatidylcholine (LPC) is the major bioactive lipid component of oxidized LDL, thought to be responsible for many of the inflammatory effects of…”
Get full text

NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation by Gatto, Jr, Gregory J, Ao, Zhaohui, Kearse, Michael G, Zhou, Mei, Morales, Cyndi R, Daniels, Erin, Bradley, Benjamin T, Goserud, Matthew T, Goodman, Krista B, Douglas, Stephen A, Harpel, Mark R, Johns, Douglas G

“…NADPH oxidase isoform-2 (NOX2) generates reactive oxygen species (ROS) that contribute to neurodegenerative and cardiovascular pathologies. However, validation…”
Get more information

The Work of Adult and Pediatric Intensive Care Unit Nurses by Douglas, Stephen, Cartmill, Randi, Brown, Roger, Hoonakker, Peter, Slagle, Jason, Schultz Van Roy, Kara, Walker, James M, Weinger, Matthew, Wetterneck, Tosha, Carayon, Pascale

“…BACKGROUND:Researchers have used various methods to describe and quantify the work of nurses. Many of these studies were focused on nursing in general care…”
Get full text

Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta by Bousette, Nicolas, Patel, Lisa, Douglas, Stephen A, Ohlstein, Eliot H, Giaid, Adel

“…Urotensin II (U-II), a novel vasoactive peptide, possesses a wide range of cardiovascular effects. U-II binds a seven transmembrane spanning G-protein coupled…”
Get full text

Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation by Bousette, Nicolas, Hu, Fu, Ohlstein, Eliot H., Dhanak, Dashyant, Douglas, Stephen A., Giaid, Adel

“…Expression of urotensin II (UII) is significantly elevated in the hearts of patients with congestive heart failure (CHF). Recent reports have also shown…”
Get full text

Conducting an efficient proactive risk assessment prior to CPOE implementation in an intensive care unit by Hundt, Ann Schoofs, Adams, Jean A, Schmid, J. Andrew, Musser, Linda M, Walker, James M, Wetterneck, Tosha B, Douglas, Stephen V, Paris, Bonnie L, Carayon, Pascale

“…Abstract Purpose To develop, conduct, and evaluate a proactive risk assessment (PRA) of the design and implementation of CPOE in an ICU. Methods We developed a…”
Get full text

Robotic and navigation systems in orthopaedic surgery: how much do our patients understand? by Jassim, Shivan S, Benjamin-Laing, Harry, Douglas, Stephen L, Haddad, Fares S

“…Technology in orthopaedic surgery has become more widespread in the past 20 years, with emerging evidence of its benefits in arthroplasty. Although patients…”
Get full text

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 by Ames, Robert S, Sarau, Henry M, Chambers, Johathan K, Willette, Robert N, Aiyar, Nambi V, Romanic, Anne M, Louden, Calvert S, Foley, James J, Sauermelch, Charles F, Coatney, Robert W, Ao, Zhaohui, Disa, Jyoti, Holmes, Stephen D, Stadel, Jeffrey M, Martin, John D, Liu, Wu-Schyong, Glover, George I, Wilson, Shelagh, McNulty, Dean E, Ellis, Catherine E, Elshourbagy, Nabil A, Shabon, Usman, Trill, John J, Hay, Douglas W. P, Ohlstein, Eliot H, Bergsma, Derk J, Douglas, Stephen A

“…Urotensin-II (U-II) is a vasoactive 'somatostatin-like' cyclic peptide which was originally isolated from fish spinal cords, and which has recently been cloned…”
Get full text

Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey by Douglas, Stephen A, Sulpizio, Anthony C, Piercy, Valerie, Sarau, Henry M, Ames, Robert S, Aiyar, Nambi V, Ohlstein, Eliot H, Willette, Robert N

“…Urotensin‐II (U‐II) and its G‐protein‐coupled receptor, GPR14, are expressed within mammalian cardiac and peripheral vascular tissue and, as such, may regulate…”
Get full text

Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteries by Bottrill, Fiona E, Douglas, Stephen A, Hiley, C Robin, White, Richard

“…The possible role of the endothelium in modulating responses to human urotensin‐II (U‐II) was investigated using isolated segments of rat thoracic aorta, small…”
Get full text

Expression of urotensin-II in human coronary atherosclerosis by Hassan, Ghada S., Douglas, Stephen A., Ohlstein, Eliot H., Giaid, Adel

“…The vasoactive peptide urotensin-II (U-II) is best known for its ability to regulate peripheral vascular and cardiac contractile function in vivo, and recent…”
Get full text

Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production by Bao, Weike, Behm, David J, Nerurkar, Sandhya S, Ao, Zhaohui, Bentley, Ross, Mirabile, Rosanna C, Johns, Douglas G, Woods, Tina N, Doe, Christopher PA, Coatney, Robert W, Ohlstein, Jason F, Douglas, Stephen A, Willette, Robert N, Yue, Tian-Li

“…Angiotensin II (Ang II) activates p38 mitogen-activated protein kinase (p38 MAPK) and increases reactive oxygen species (ROS), but the nature of the…”
Get full text

Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries by Stirrat, A, Gallagher, M, Douglas, S A, Ohlstein, E H, Berry, C, Kirk, A, Richardson, M, MacLean, M R

“…The peptide human urotensin-II (hUT-II) and its receptor have recently been cloned. The vascular function of this peptide in humans, however, has yet to be…”
Get more information